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Abstract
Several of the cellular alterations involved in atrial fibrillation (AF) may be
linked to mitochondrial function and altered microRNA (miR) expression. A
majority of studies on human myocardium involve right atrial (RA) tissue
only. There are indications that AF may affect the two atria differentially. This
study aimed to compare interatrial differences in mitochondrial respiration
and miR expression in the RA versus left atrium (LA) within patients with
sinus rhythm (SR) and AF. Thirty-seven patients with AF (n = 21) or SR
(n = 16), undergoing coronary artery bypass surgery and/or heart valve sur-
gery, were included. Myocardial biopsies were obtained from RA and LA
appendages. Mitochondrial respiration was assessed in situ in permeabilized
myocardium. MiR array and real-time quantitative polymerase chain reaction
were performed to evaluate miR expression. Mitochondrial respiratory rates
were similar in RA versus LA. Expression of miR-100, -10b, -133a, -133b,
-146a, -155, -199a-5p, -208b, and -30b were different between the atria in both
SR and AF patients. In contrast, differential expression was observed between
RA versus LA for miR-93 in patients with SR only, and for miR-1, -125b,
-142-5p, -208a, and -92b within AF patients only. These results indicate that
mitochondrial respiratory capacity is similar in the RA and LA of patients with
SR and AF. Differences in miR expressional profiles are observed between the
RA versus LA in both SR and AF, and several interatrial differences in miR
expression diverge between SR and AF. These findings may contribute to the
understanding of how AF pathophysiology may affect the two atria differently.
Introduction
Atrial fibrillation (AF) is prevalent in the increasingly
aging population, and is associated with serious compli-
cations (Go et al. 2001; Fuster et al. 2011). The underly-
ing pathophysiology of AF is still not fully understood
(Mathew et al. 2009). There are indications that AF may
affect the two atria differentially, and because the human
right atrial (RA) appendage is more accessible for sam-
pling than the left atrial (LA) appendage, investigations
of the human LA are particularly scarce (Caballero et al.
2010). Since the majority of studies investigating human
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
2014 | Vol. 2 | Iss. 8 | e12124
Page 1
Physiological Reports ISSN 2051-817X
tissue are restricted to the RA only, there is limited
knowledge regarding interatrial differences in AF and
sinus rhythm (SR) in human myocardium.
Despite the central role of mitochondrial respiration in
cardiomyocyte function, research on mitochondrial func-
tion in AF is limited. Many of the pathophysiological
processes implicated in AF are linked to mitochondrial
function, including calcium homeostasis (Mihm et al.
2001; Neef et al. 2010; Reilly et al. 2011), formation of
reactive oxygen species (ROS) (Mihm et al. 2001), and
alterations of oxygen consumption (White et al. 1982).
Findings of altered levels of phosphocreatine (Ausma
et al. 2000), electron transport chain proteins (Reilly et al.
2011), and differences in mitochondrial distribution (Mo-
rillo et al. 1995) further implicate that mitochondria have
a role in AF.
MicroRNA (miR) regulates gene expression through
inhibition or degradation of mRNA and has been
implicated as an important influential element in mito-
chondrial respiration (Li et al. 2012; Sripada et al.
2012) and cardiac arrhythmias (Luo et al. 2010; Wang
et al. 2011), including AF (Shi et al. 2013; Santulli et al.
2014).
We recently presented a report where we compared
biatrial mitochondrial function and miR expression
between patients with AF versus patients with SR, and
found that AF was associated with altered miR expression
and elevated maximal mitochondrial respiratory rate as
compared to SR (Slagsvold et al. 2014). In this paper, we
assess interatrial differences in mitochondrial respiration
and miR expression within each of these two patient
groups.
Methods
Patients
A total of 37 patients with either SR (n = 16) or a history
of AF (n = 21) scheduled for elective isolated coronary
artery bypass grafting (CABG) surgery, mitral valve
replacement (MVR) surgery, aortic valve replacement
(AVR) surgery, or combined CABG/AVR surgery at St.
Olav’s Hospital, Trondheim University Hospital, Norway
were included. Patients with either paroxysmal AF (pAF)
(n = 11) or chronic AF (cAF) (n = 10) were included in
the AF group. Blinding of patient characteristics was
ensured until completion of data collection and process-
ing. The study conformed to the principles outlined in
the Declaration of Helsinki, and was approved by the
Regional Committee for Medical Research Ethics of
Norway. Written informed consent was obtained from
patients prior to inclusion.
Study design
Standard pre- and peroperative procedures of the Depart-
ment of Cardiothoracic Surgery, St. Olav’s Hospital were
followed. Thiopental, fentanyl, propofol, and cisatracuri-
um were administered intravenously for anesthetics. Iso-
flurane was given during pulmonary ventilation, but not
during cardiopulmonary bypass (CPB). CPB was per-
formed at mild hypothermia of 32–34°C. Standard St.
Thomas (Martindale Pharmaceuticals, Essex, United King-
dom) crystalloid or blood cardioplegia was administered
for myocardial protection. Cardiac rhythm was monitored
pre- and peroperatively by electrocardiography.
Tissue samples
Biopsies from the RA appendage were obtained during
RA cannulation, and biopsies from the LA appendage
during CPB. Each biopsy was immediately divided into
two; one piece was promptly submerged in an ice-cold
preservation solution for assessment of mitochondrial
function, and the other snap-frozen in liquid nitrogen
and kept on 80°C for miR analyses.
Mitochondrial respiration in situ
Mitochondrial respiration rates were measured in situ
according to methods thoroughly described by other
authors (Veksler et al. 1987; Saks et al. 1998; Zoll et al.
2002; N’Guessan et al. 2004; Kuznetsov et al. 2008). The
myocardium was separated from connective tissue under
a microscope, and myocardial cell membranes permeabi-
lized by 50 lg/mL saponin for 30 min at 4°C while
leaving mitochondrial membranes intact. This was fol-
lowed by a > 10 min rinsing cycle in pure storage solution
(2.77 mmol/L CaK2EGTA, 7.23 mmol/L K2EGTA
(100 nmol/L free Ca2+), 6.56 mmol/L MgCl2 (1 mmol/L free
Mg2+), 20 mmol/L taurine, 0.5 mmol/L dithiothreitol (DTT),
and 20 mmol/L imidazole 50 mmol/L potassium-methane-
sulfonate (CH3KO3S), 5.7 mmol/L Na2ATP, 15 mmol/L
phosphocreatine (PCr) (pH 7.1 at 22°C)), and subsequent
10 min rinsing in respiration solution (2.77 mmol/L
CaK2EGTA, 7.23 mmol/L K2EGTA (100 nmol/L free Ca
2+),
1.38 mmol/L MgCl2 (1 mmol/L free Mg
2+), 20 mmol/L tau-
rine, 0.5 mmol/L dithiothreitol (DTT), and 20 mmol/L imid-
azole (pH 7.1 at 22°C), 90 mmol/L potassium-
methanesulfonate (CH3KO3S), 10 mmol/L sodium-methane-
sulfonate (CH3SO3Na), 3 mmol/L K2HPO4, 10 mmol/L glu-
tamate, 4 mmol/L malate, and 2 mg/mL bovine serum
albumin). Mitochondrial respiratory assessment of the per-
meabilized atrial myocardium was performed by use of a
Clark-type microcathode oxygen electrode (Strathkelvin
Instruments, Glasgow, UK) covered by a fluorinated
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ethylene propylene (FEP) membrane, with tissue sub-
merged in 3 mL respiration solution maintained at 22°C.
Assessment of respiration in the presence of respiratory
complex I substrates glutamate and malate, without aden-
osine diphosphate (ADP) (basal respiratory rate, V0), was
followed by assessment of respiration in the presence of
subsaturating 0.1 mmol/L ADP (VADP). A volume of
20 mmol/L creatine was supplemented prior to measure-
ment of Vcreatine, and subsequently the addition of a satu-
rating 2 mmol/L ADP allowed assessment of maximal
respiration rate (Vmax) with glutamate and malate as sub-
strates for complex I through IV of the electron transport
chain. Vsuccinate was measured in the presence of complex II -
substrate succinate (10 mmol/L) and subsequent complex I
inhibition by amytal (1 mmol/L) preceded assessment
of complex II (Vamytal). Ascorbate (0.5 mmol/L) and N,N,
N’,N’-tetramethyl-p-phenylenediamine (TMPD, 0.5 mmol
/L) was added to induce complex IV activity (VascorbateTMPD)
and before completion irreversible inhibition of complex
IV by azide (4 mmol/L) allowed assessment of Vazide.
Respiratory rates are given as micromoles O2 per minute
per gram dry weight myocardial tissue (lmol O2/min/g
dw). Acceptor control ratio (ACR), as calculated by the
ratio Vmax/V0, estimates degree of coupling between
oxidation and phosphorylation. The ratio of VADP/Vmax
quantifies mitochondrial sensitivity to ADP. Percent
increase in respiratory rate after addition of creatine is
given (↑RR Cr). The ratio Vamytal/Vmax estimates excess
respiration of the cytochrome oxidase complex. Estimation
of the apparent constant of Michaelis for ADP was
calculated in the absence (appKm
(ADPCr)) and presence of
creatine (appKm
(ADP+Cr)) (N’Guessan et al. 2004).
MicroRNA expression
RNA isolation, miR array and real-time quantitative
polymerase chain reaction (qRT-PCR) were performed by
Exiqon Services, Vedbaek, Denmark. RNA quality was
ascertained by use of Agilent 2100 bioanalyzer (Agilent
Technologies, Inc., Santa Clara, CA) prior to labeling for
miR array by use of Exiqon’s miRCURY LNATM microR-
NA Hi-Power Labeling Kit, Hy3TM/Hy5TM and subsequent
hybridization on the miRCURY LNATM microRNA Array
6th gen (Exiqon, Denmark). Capture probes targeting all
human miRs registered in miRBASE 16.0 were applied.
Hybridization was performed with a Tecan HS4800TM
hybridization station (Tecan, Austria). Agilent G2565BA
Microarray Scanner System (Agilent Technologies, Inc.)
was used to scan the array slides, followed by image
analysis with ImaGene 9 (miRCURY LNATM microRNA
Array Analysis Software, Exiqon, Denmark). Background
correction of quantified signals was performed prior to
normalization by applying the global Lowess (LOcally
WEighted Scatterplot Smoothing) regression algorithm.
miR RT-qPCR was performed with miRCURY LNATM
Universal RT miRNA PCR pick and mix custom panel,
and LightCycler 480 Real-Time PCR System (Roche,
USA) was used for amplification. PCR was performed for
miR-1, -100, -106a, -106b, -10b, -125b, -133a, -133b,
138-1*, -142-5p, -144, -146a, -155, -15b, -17, -187, -18a,
-18b, -191, -193a-3p, -199a-5p, -19a, -19b, -208a, -208b,
-21, -23a, -25, -26a, -26b, -29b, -30a, -30b, -328, -363,
-451, -486-5p, -590-5p, -600, -92a, -92b, -93. Roche LC
software was applied for analyses of amplification curves
both in determining crossing points (Cp) and melting
curves. Algorithms similar to the LinReg software were
used to quantify amplification efficiency. Normalization
was based on the average of 5 normalization assays
detected in all samples. Results of miR expression after
RT-qPCR are presented as normalized crossing point
(dCp, refers to the crossing point (Cp) of the specific
miR after subtracting the average Cp of the normaliza-
tion miRs).
Statistical analysis
SPSS 21.0 for Mac (IBM SPSS Statistics, Chicago, Illinois)
was used for statistical analyses. Paired students t-test was
applied for comparison of RA versus LA within each
patient. Pearson’s Chi2 and Fisher’s exact test were used
for categorical data. A two-tailed P-value <0.05 was con-
sidered significant. Hochberg–Bonferroni-correction was
applied to statistical analyses of miR expression. Graph-
Pad Prism 5 (GraphPad Software, Inc., San Diego, CA)
was used for graphics.
Results
Table 1 provides an overview of clinical data. The groups
were comparable with regards to clinical characteristics,
with the exception of a statistically significant larger per-
centage of mitral valve disease in patients with AF as
compared to SR. Information on LA diameter was avail-
able for 12 patients in SR and 13 in AF and indicated a
nonsignificant tendency of LA dilatation in patients with
AF. All patients diagnosed with cAF and one of the
patients with pAF were in AF on preoperative electrocar-
diography.
Mitochondrial respiration
No significant differences were observed in paired com-
parison of mitochondrial respiration rates in samples
from the RA versus LA within either SR or AF (Fig. 1),
nor were there any differences in other parameters of
mitochondrial function (Table 2).
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 8 | e12124
Page 3
K. H. Slagsvold et al. Left vs. Right Atrium in SR or AF
MicroRNA
MiR array revealed 75 miRs that were differentially regu-
lated between the LA and RA (data not shown). Array
was used as a preliminary explorative study to identify
miRs for investigation with qRT-PCR. qRT-PCR revealed
increased LA expression of miR-10b, -133a, -133b, and
-30b, and decreased expression of miR-100, -146a, -155,
-199a-5p, and -208b as compared to RA in both the SR
group and the AF group (Fig. 2).
MiR-93 displayed decreased expression in the LA as
compared to the RA within patients with SR only
(Fig. 2A).
In samples from AF patients, increased expression of
miR-1 and -208a and decreased expression of miR-125b,
-142-5p, and -92b was observed in the LA as compared
to the RA in addition to the differences described in both
patient groups (Fig. 2B).
Discussion
Comparison of the LA and RA revealed similar mitochon-
drial respiratory function in the two atria for patients
with SR as well as in patients with AF. Mitochondrial res-
piration has never previously been compared between the
LA and RA of patients with AF, and to our knowledge,
only one study has previously assessed mitochondrial
function in both human atria, where atrial tissue from
two patients without known cardiac disease, and three
patients with chronic heart failure were examined, dem-
onstrating similar mitochondrial respiration rates in RA
as compared to LA in agreement with our study (Lemieux
et al. 2011). These results indicate that, although a differ-
ence of interatrial pressures normally exists between the
RA and LA, the difference in workload does not appear
to have detectable impact on mitochondrial respiratory
capacity. These findings are of interest because they may
increase our understanding of how results obtained from
one myocardial location may relate to another, especially
due to the increased attainability of RA appendage tissue
Table 1. Patient characteristics and perioperative parameters.
SR
(n = 16)
AF
(n = 21) P
Age, l  SD 71  8 70  8 ns
Female gender, % 25 24 ns
Aortic valve disease, % 31 43 ns
Mitral valve disease, % 44 76 <0.05
Chronic obstructive pulmonary
disease, %
6 5 ns
Coronary artery disease, % 75 81 ns
Diabetes Mellitus, % 13 16 ns
Hypertension, % 50 48 ns
Previous cerebral insult, % 0 5 ns
Previous myocardial infarction, % 31 24 ns
Normal left atrial diameter
(≤40 mm), %
83 46 ns
Dilated left atrium (≥41 mm), % 17 54 ns
LV EF, l  SD 49  8 52  8 ns
Combined CABG/AVR-surgery, % 13 24 ns
Isolated AVR-surgery, % 19 19 ns
Isolated CABG-surgery, % 63 48 ns
Isolated MVR-surgery, % 6 10 ns
ACE-inhibitor/ATII inhibitor, % 44 57 ns
Antiarrhythmic agents, % 6 5 ns
Beta blocker, % 63 76 ns
Calcium antagonist, % 31 24 ns
Diuretics, % 38 48 ns
Digitalis, % 0 5 ns
l, mean; SD, standard deviation; SR, sinus rhythm; AF, atrial fibril-
lation; AVR, aortic valve replacement; MVR, mitral valve replace-
ment; CABG, coronary artery bypass graft; LV EF, left ventricular
ejection fraction; ACE, angiotensin converting enzyme; ATII,
angiotensin II receptor.
Table 2. Mitochondrial parameters of the right (RA) versus left atrium (LA) in patients with sinus rhythm (SR) or atrial fibrillation (AF).
SR AF
LA (n = 10) RA (n = 16)
P
LA (n = 21) RA (n = 21)
Pl  SD l  SD l  SD l  SD
Vamytal/Vmax 1.3  0.5 1.1  0.3 ns 1.0  0.3 1.0  0.3 ns
VADP/Vmax 0.5  0.3 0.4  0.3 ns 0.5  0.1 0.4  0.2 ns
ACR 4.2  2.4 4.9  3.9 ns 4.5  1.7 5.0  1.9 ns
appKm
(ADPCr) 210  168 194  149 ns 141  77 158  101 ns
appKm
(ADP+Cr) 76  80 101  123 ns 43  34 65  39 ns
↑RR Cr 65  50 73  57 ns 69  33 63  35 ns
Data presented as mean  SD. n, number of patients; SR, sinus rhythm; AF, atrial fibrillation; Vamytal/Vmax, quantification of excess respiration
of the cytochrome oxidase complex; VADP/Vmax, ADP sensitivity ratio; ACR, acceptor control ratio;
appKm
(ADPCr) approximate Michaelis-Menten
constant for ADP (lM) in the absence of creatine; appKm
(ADP+Cr), apparent Michaelis-Menten constant for ADP (lM) in the presence of
creatine; ↑RR Cr, increase in respiration rate after addition of creatine.
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in investigations involving the human myocardium
(Ausma et al. 2000; Mihm et al. 2001; Kim et al. 2005;
Reilly et al. 2011). It could have been expected that
mitochondrial respiratory capacity would have been
increased in the LA as compared to the RA of patients
with AF due to an increased frequency of elevated LA
pressure in this patient group (Stefanadis et al. 2001).
However, our study does not support this notion. This
may, however, depend on the extent of LA dilatation, and
it must be kept in mind that our patient population did
not reveal significant differences in LA diameter between
the patient populations in AF versus SR; thus it cannot
A
B
Fig. 1. Mitochondrial respiration rates within the left (LA) versus right atrium (RA) of patients with (A) sinus rhythm (SR) and (B) atrial
fibrillation (AF). Respiratory rates are given as mean  SEM (error bars) in lmol O2/minute/g dryweight myocardial tissue, and are measured
after subsequent addition of the following substrates and inhibitors: V0, basal respiration with glutamate and malate as substrates for Complex
I of the electron transport chain; VADP, respiration in the presence of a subsaturating amount of adenosine diphosphate (ADP); Vcreatine,
respiration rate after creatine supplement; Vmax, maximal respiration rate in the presence of glutamate and malate with a saturating amount of
ADP; Vsuccinate, respiration rate with Complex II substrate succinate; Vamytal, respiration during inhibition of complex I by amytal; VascorbateTMPD,
respiratory rate with induction of complex IV activity through ascorbate (0.5 mmol/L) and N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD,
0.5 mmol/L), Vazide, respiration after irreversible inhibition of complex IV by azide.
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be excluded that the results may differ in other patient
populations with greater differences in LA diameter.
We observed a number of interatrial differences in miR
expression that are common to both patient groups,
whereas there are other interatrial differences in miR
expression that differ between SR and AF patients. Differ-
ences in miR expression between LA and RA that are
found in both patients groups may be ascribed to ana-
tomic and physiological differences in the RA as com-
pared to the LA (increased LA expression of miR-10b,
-133a, -133b, and -30b, and decreased expression of miR-
100, -146a, -155, -199a-5p, – 208b, as compared to RA).
The reduced expression of miR-93 in the LA versus RA
of patients with normal SR may also be related to a dif-
ference of anatomical and physiological regions. It has
been demonstrated that miR-93 has proangiogenic effects,
promotes perfusion recovery after ischemia, and is
associated with improved cell survival after hypoxia and
serum starvation in endothelial and skeletal muscle cells
(Hazarika et al. 2013).
Interatrial differences found in AF patients only include
increased LA expression of miR-1 and -208a and
decreased expression of miR-125b, -142-5p, and -92b as
compared to the RA. Whereas electrophysiological map-
ping has indicated that myocardial areas in both the RA
and LA may be responsible for activating atrial premature
complexes in patients with AF (Natale et al. 2000), there
are indications that electrical remodeling is altered differ-
entially in RA as compared to LA in patients with AF
(Caballero et al. 2010). Overexpression of miR-1 has been
implicated in promoting arrhythmogenesis (Terentyev
et al. 2009). Both overexpression and underexpression of
the cardiospecific miR-208a have been demonstrated to
induce cardiac arrhythmia by disturbing atrial electro-
physiology in mice (Callis et al. 2009). Blocking cardiac
miR-208a expression prevented cardiac remodeling and
dysfunction and promoted health and survival of rats in a
study of chronic hypertension and diastolic heart failure
(Montgomery et al. 2011). In our previous report where
we compared atrial miR expression between patients with
A
B
Fig. 2. Significant differences in microRNA (miR) expression between the left (LA) versus right atrium (RA) within patients with (A) sinus rhythm
(SR) and patients with (B) atrial fibrillation (AF). dCp, normalized crossing point. Circles indicate interatrial differences in miR expression that are
found exclusively within either SR or AF patients. Error bars indicate standard deviation. *P < 0.05.
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SR versus AF, miR-208a expression was significantly lower
in AF patients as compared to patients with SR in both
atria (Slagsvold et al. 2014). MiR-125b is upregulated
under hypoxia and upon stimulation with VEGF in skele-
tal muscle (Muramatsu et al. 2013). It has been demon-
strated that miR-142-5p regulates genes involved in cell
cycle control and increases proliferation and DNA synthe-
sis in vascular smooth muscle cells of rats (Kee et al.
2013). Reduced myocardial expression of miR-92b has
been demonstrated in mice with experimentally induced
heart failure (Dirkx et al. 2013).
Investigations of miR expression in human myocar-
dium are still at an early stage, and this study provides
information of myocardial miR expression that is strictly
descriptive in nature. Moreover, these data do not pro-
vide information as to whether any direct link exists
between miR expression and mitochondrial function.
Many unknown factors still need clarification, and even
associative observations are valuable in the process of
obtaining an understanding of miR in cardiovascular
pathophysiology. Although direct comparison of the
results are precluded due to differences in patient charac-
teristics, we identified two other studies reporting com-
parative assessment of miR expression in the LA versus
RA, one investigating patients with AF and valvular heart
disease (Cooley et al. 2012), and the other patients with
rheumatic mitral valve disease and either SR or AF (Liu
et al. 2014). It is evident that continued research is neces-
sary to establish representativeness of miR expression for
specific patient populations, especially due to the com-
mon occurrence of concurrent heart disease in patients
with AF.
Study limitations
The atrial appendage is selected for investigation as it
constitutes the most accessible location for sampling
human myocardial tissue. Whether AF-related alterations
on the cellular level prevail throughout the atrium has
not yet been assessed in humans, thus it has not been
ascertained that tissue from the atrial appendage is repre-
sentative to the remaining atrial myocardium of patients.
However, it has been demonstrated that structural AF-
related alterations in the atrial appendages of goats corre-
sponded to that of the remaining atrial myocardium
(Ausma et al. 1997).
Due to the frequent coexistence of cardiac disease in
AF, distinguishing AF-related alterations from those of
concomitant heart disease presents a challenge in investi-
gations of AF. Although the clinical characteristics of the
patients groups in our study were comparable in most
aspects, there was a difference in prevalence of mitral
valve disease. Although investigations of “lone” AF have
been demonstrated in animal models (Morillo et al. 1995;
Ausma et al. 1997), a potential interference of comorbidi-
ty cannot be excluded in our clinical study and further
research is required to verify reproducibility.
Our investigation provides a description of associative
alterations in miR expression and mitochondrial function.
Further investigations are required to explore causal rela-
tions between mitochondrial respiration, miR, and AF.
Conclusion
Mitochondrial respiration is similar between the RA and
LA in patients with normal SR as well as in AF. Interatrial
differences in miR expression are observed within both
patients with SR and patients with AF, and the interatrial
differences in miR expression profiles diverge between
patients with normal SR and patients with AF.
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